|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Institute on Aging (NIA) |
| Information provided by: | National Institute on Aging (NIA) |
| ClinicalTrials.gov Identifier: | NCT00270686 |
Purpose
The purpose of this study is to examine cardiovascular and musculoskeletal complications of heritable connective tissue disorders (HDCT) and the natural history of these complications.
| Condition |
|
Ehlers-Danlos Syndrome Marfan Syndrome Stickler Syndrome |
| MedlinePlus related topics: | Connective Tissue Disorders Ehlers-Danlos Syndrome Marfan Syndrome |
| Study Type: | Observational |
| Study Design: | Cohort, Prospective |
| Official Title: | Clinical and Molecular Manifestations of Heritable Disorders of Connective Tissue |
Whole blood, frozen fibroblast cultures from skin or other tissue samples, fixed tissue, plasma
| Estimated Enrollment: | 300 |
| Study Start Date: | June 2003 |
| Estimated Study Completion Date: | December 2012 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|
1
Longitudinal Study Arm: 450 participants who will be involved in extensive testing and will be followed longitudinally. Each participant spends approximately 2 days undergoing clinical evaluations. The clinical visits occur every 1 to 5 years based on the subject's age, medical condition, and ability to travel to the study location.
|
|
2
Mutational Analysis Arm: There is an upper limit of 1385 participants for this arm. Participants may come to the NIA Clinical Research Unit for a one-time visit (less than one day in length), or they may enroll off-site by sending in bloods, saliva, or bucca samples for the DNA analysis.
|
|
3
Genome Protocol Arm: This arm consists of participants who have been previously enrolled under NHGRI protocol 97-HG-0089, presently inactive. The samples are housed at NIA facilities for use by the PI and collaborators approved by the NIA IRB.
|
The purpose of this research is to investigate a group of genetic disorders called the Hereditary Disorders of Connective Tissue and describe the health problems associated with these conditions. These disorders and their prominent symptoms include:
People who have a known or strongly suspected diagnosis are eligible to participate. At the NIA ASTRA unit at Harbor Hospital, a study investigator will obtain a detailed medical history and perform a physical examination on participants. These evaluations will occur every 2 years for 5 years. Additional studies may include an echocardiogram, ECG, Holter study, bone densitometry, blood and urine tests, magnetic resonance imaging (MRI)/MRA studies and vascular studies. A skin biopsy may be done with a separate consent for some participants. Questionnaires about pain and quality of life will be completed by participants.
Eligibility
| Ages Eligible for Study: | 12 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Participants may be self-referred or referred by physician, nurses, genetic counselors, or other health professionals, support groups, and family members. With the exception of male and minority participants we are not actively recruiting new research participants because the number of self-referrals through support groups and enrolled family members have been sufficient.
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: NIA Recruiter | 410-350-3941 | NIAStudiesRecruitmetn@mail.nih.gov |
| United States, Maryland | |||||
| Harbor Hospital | Recruiting | ||||
| Baltimore, Maryland, United States, 21225 | |||||
| Contact: Leslie Sloper, RN 410-350-7391 sloperlj@mail.nih.gov | |||||
| Principal Investigator: Nazli McDonnell, MD, PhD | |||||
| Principal Investigator: | Nazli McDonnell, MD, PhD | National Institute on Aging (NIA) |
More Information
| Responsible Party: | National Institute of Aging ( Nazli McDonnell, M.D., Ph.D. Principle Investigator ) |
| Study ID Numbers: | AG0060 |
| First Received: | December 27, 2005 |
| Last Updated: | August 22, 2008 |
| ClinicalTrials.gov Identifier: | NCT00270686 |
| Health Authority: | United States: Federal Government |
|
|
|
|
|